Evidence map›Paper›PMID 41372146›Full record

ArticleNature communications2025

Convergence of plasmid-driven virulence and antibiotic resistance in Escherichia coli.

Zheng Jie Lian, Nguyen Thi Khanh Nhu, Chitra Ravi, Chyden Chang, Irene Martinez-Roman, Minh-Duy Phan, Mark A Schembri

Abstract read
In one paragraph

Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Virulence · 2026
    Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Deciphering the Implications ofPathogens (Basel, Switzerland) · 2026
    Review
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Zheng Jie LianInstitute for Molecular Bioscience, The University of Queensland, Brisbane, QLD, Australia.ORCID http://orcid.org/0000-0002-3054-1866
Nguyen Thi Khanh NhuInstitute for Molecular Bioscience, The University of Queensland, Brisbane, QLD, Australia.ORCID http://orcid.org/0000-0002-0158-850X
Chitra RaviInstitute for Molecular Bioscience, The University of Queensland, Brisbane, QLD, Australia.
Chyden ChangInstitute for Molecular Bioscience, The University of Queensland, Brisbane, QLD, Australia.ORCID http://orcid.org/0000-0002-9865-1949
Irene Martinez-RomanInstitute for Molecular Bioscience, The University of Queensland, Brisbane, QLD, Australia.
Minh-Duy PhanInstitute for Molecular Bioscience, The University of Queensland, Brisbane, QLD, Australia. m.phan1@uq.edu.au.ORCID http://orcid.org/0000-0002-3426-1044
Mark A SchembriInstitute for Molecular Bioscience, The University of Queensland, Brisbane, QLD, Australia. m.schembri@uq.edu.au.ORCID http://orcid.org/0000-0003-4863-9260

Funding

Department of Education and Training | Australian Research Council (ARC) DP230101930Department of Health | National Health and Medical Research Council (NHMRC) 2037698Department of Health | National Health and Medical Research Council (NHMRC) APP2001431
6 · The paper itself

Abstract

Plasmids are major vehicles for the spread of antibiotic resistance genes. Some plasmids additionally carry virulence genes that enhance host pathogenicity. The convergence of resistance and virulence genes on the same plasmid poses significant risk, providing a mechanism to create pathogens that cause severe disease with limited treatment options. Colicin V (ColV)-like plasmids (ColVLPs) are virulence plasmids frequently carried by extra-intestinal pathogenic E. coli (ExPEC) that cause human and avian infection. Here, by generating and analysing a ColVLP database, we demonstrate that ColVLPs form four distinct sub-groups, characterised by genes encoding for Colicins V and M, with differing virulence and antimicrobial resistance gene carriage. Three of these sub-groups possess moderate-high resistance towards multiple antibiotic classes. We further describe ColVLP co-integrates that have acquired extensive resistance profiles, including against last line colistin, through recombination with co-resident plasmids. Using pMS7163A, a ColVLP from a virulent ExPEC strain, we also demonstrate that the ColVLP-encoded outer membrane protease virulence factor OmpTp works co-operatively with its chromosomal homolog to enhance ExPEC resistance against human cathelicidin (LL-37), an antimicrobial peptide expressed in the urinary tract. Together, our work characterises ColVLPs as high-risk mobile genetic elements that amplify the convergence of resistance and virulence in ExPEC.

Indexed as

Drug Resistance, BacterialEscherichia coliPlasmidsAnimalsAnti-Bacterial AgentsColicinsEscherichia coli InfectionsEscherichia coli ProteinsHumansMicrobial Sensitivity TestsVirulenceVirulence FactorsAnti-Bacterial AgentsColicinsEscherichia coli ProteinsVirulence Factors

Identifiers

PMID41372146
PMCPMC12804835

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.